Specialty Pharmacy

Amgen has announced positive results of a phase 3 study evaluating its investigational drug, ABP 501, a biosimilar candidate to AbbVie's fully human anti-tumor necrosis factor alpha monoclonal antibody, adalimumab, in patients with moderate-to-severe rheumatoid arthritis.

Death risk twice as high for survivors who smoke compared with non-smokers.

Use of appropriate technology in the pharmaceutical supply chain can help reduce costs to organizations and improve care for patients.

Avella Specialty Pharmacy announced today that it has been selected by GlaxoSmithKline as one of a select group of pharmacies authorized to continue to distribute Benlysta, a medication approved by the FDA for the treatment of systemic lupus erythematosus in patients who have previously received other therapies.

The news of Margaret A. Hamburg, MD, resigning from her long-standing post as FDA Commissioner stirred memories of her success with improving access to emergency contraception, but more so her struggles with regulating drug compounding following a deadly fungal meningitis outbreak traced to a compounding pharmacy's tainted drugs.

Symptoms include airflow obstruction, bronchial hyperresponsiveness, and airway inflammation.

Phase 3 trial for polycythemia vera drug significantly improved hematocrit control without the need for phlebotomy.

Progression-free survival improved from treatment during phase 3 trial.

As the role of the pharmacist continues to expand to meet the health care needs of patients nationwide, Parata Systems and Pharmacy Times are gearing up for the sixth annual program recognizing outstanding pharmacists, technicians, student pharmacists and industry advocates. The NextGeneration Pharmacistâ„¢, the industry's leading national awards program, begins accepting nominations today for these prestigious awards.

Research identifies how tumors resist current treatments.

Treatment was previously designated as a breakthrough therapy for bladder cancer.

The FDA today granted accelerated approval to a drug that treats breast cancer in postmenopausal women by attacking molecules that promote cancer cell growth.

Amgen and its subsidiary, Onyx Pharmaceuticals, have submitted a supplemental New Drug Application (sNDA) to the FDA for their proteasome inhibitor, carfilzomib (Kyprolis), in the hopes of expanding the drug's indication to include patients with relapsed multiple myeloma who have received at least 1 prior therapy.

An examination of the pathophysiology of asthma.

Thomas Morrow, MD, chief medical officer at Next IT, discusses the future of patient care with the use of virtual health assistants.

Technology locates tumors otherwise obscured by dense breast tissue on a mammogram.

Strong association found between corticosteroids and risk of venous thromboembolism.

A review of the pathology of asthma and COPD, including the role of the immune system, along with the mechanisms behind the hypercapnia and hypoxemia of COPD, and the blue bloater vs. pink puffer pseudodichotomy.

Smokers have greater risk for recurrence of cancer.

Daily fixed-dose combination tablet contains 800 mg of darunavir and 150 mg of cobicistat.

Cost and cold chain concerns drive a decrease in shipping via air freight.

Use of a hormonal contraceptive for at least 5 years linked to potential increase in development of glioma of the brain.

Repurposing drugs that block sodium channels may offer a novel therapy for cancer.

The FDA today approved Bristol-Myers Squibb Company's atazanavir and cobicistat for the treatment of HIV-1 infection in adults in combination with other antiretroviral agents.

Pharmacist collaboration with physicians during a national shortage of intravenous trimethoprim/sulfamethoxazole may have helped mitigate negative treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumonia.

The FDA today approved the expanded use of a breakthrough therapy for the treatment of a rare form of cancer that attacks the immune system.

System would provide more treatment options for patients along with evidence of drug safety and efficacy for regulators.

Kidneys transplanted from infant who died days after birth.